| 201096-100MG |
|
NA |
(11aR)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C41H47O4P |
|
|
|
| 201096-25MG |
|
NA |
(11aR)-3,7-Bis((4-(1,1-dimethylethyl)phenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C41H47O4P |
|
|
|
| 201095-1G |
|
NA |
(11aS)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C53H39O4P |
|
|
|
| 201095-100MG |
|
NA |
(11aS)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C53H39O4P |
|
|
|
| 201095-25MG |
|
NA |
(11aS)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C53H39O4P |
|
|
|
| 201094-1G |
|
NA |
(11aR)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C53H39O4P |
|
|
|
| 201094-100MG |
|
NA |
(11aR)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C53H39O4P |
|
|
|
| 201094-25MG |
|
NA |
(11aR)-3,7-Bis(1-pyrenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C53H39O4P |
|
|
|
| 201093-1G |
|
NA |
(11aS)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C33H29Cl2O4P |
|
|
|
| 201093-100MG |
|
NA |
(11aS)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C33H29Cl2O4P |
|
|
|
| 201093-25MG |
|
NA |
(11aS)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C33H29Cl2O4P |
|
|
|
| 201092-1G |
|
NA |
(11aR)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C33H29Cl2O4P |
|
|
|
| 201092-100MG |
|
NA |
(11aR)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C33H29Cl2O4P |
|
|
|
| 201092-25MG |
|
NA |
(11aR)-3,7-Bis(4-chlorophenyl)-10,11,12,13-tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C33H29Cl2O4P |
|
|
|
| 201091-1G |
|
NA |
(11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C49H39O4P |
|
|
|
| 201091-100MG |
|
NA |
(11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C49H39O4P |
|
|
|
| 201091-25MG |
|
NA |
(11aS)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C49H39O4P |
|
|
|
| 201090-1G |
|
NA |
(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
1G |
C49H39O4P |
|
|
|
| 201090-100MG |
|
NA |
(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
100MG |
C49H39O4P |
|
|
|
| 201090-25MG |
|
NA |
(11aR)-10,11,12,13-Tetrahydro-10,10,13,13-tetramethyl-5-hydroxy-3,7-di-9-phenanthrenyl-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
≥98%,99%e.e.
|
25MG |
C49H39O4P |
|
|
|
